Medicare Enrolled
Dr. Brian Flanagan, M.D.
Interventional Pain Medicine Physician · Dallas, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Flanagan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Flanagan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Flanagan
Dr. Brian Flanagan is an interventional pain medicine physician in Dallas, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Flanagan performed 4,541 Medicare services across 1,328 unique beneficiaries.
Between the years covered by Open Payments, Dr. Flanagan received a total of $5,982 from 58 pharmaceutical and/or device companies across 322 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional pain medicine physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Flanagan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 20% volume in TX
$5,982 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,541
Medicare services
Top 20% in TX for interventional pain medicine physician
1,328
Unique beneficiaries
$105
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~227 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,701 | $86 | $486 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
1,006 | $59 | $97 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
914 | $235 | $700 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
163 | $20 | $320 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
143 | $31 | $124 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
83 | $39 | $152 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
78 | $109 | $3,853 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
78 | $40 | $171 |
| Spinal drug pump reprogramming and refill A physician electronically adjusts the settings of a spinal drug infusion pump and refills its medication reservoir. |
60 | $68 | $798 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
40 | $47 | $1,195 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
36 | $120 | $738 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
24 | $115 | $4,162 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
24 | $67 | $2,182 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
24 | $64 | $1,432 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
23 | $201 | $4,598 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
22 | $101 | $4,154 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
22 | $57 | $2,082 |
| Spinal scar tissue removal, multiple sessions A procedure to remove scar tissue within the spinal canal, performed in multiple sessions during a single day. |
19 | $178 | $2,356 |
| Spinal nerve root injection with imaging guidance An injection of anesthetic or steroid medication into a single nerve root in the upper or middle spine. The procedure uses imaging guidance to ensure accurate placement. |
17 | $126 | $3,929 |
| Facet joint nerve destruction, single joint This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint. |
17 | $195 | $4,925 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint. |
17 | $69 | $1,927 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
15 | $21 | $443 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
15 | $15 | $58 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,982
Total received (2018-2024)
Avg $855/year across 7 years
Top 40% in TX for interventional pain medicine physician
58
Companies
322
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,982 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$562
2023
$529
2022
$523
2021
$396
2020
$458
2019
$1,262
2018
$2,252
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Nevro Corp.
$836
Abbott Laboratories
$633
Collegium Pharmaceutical, Inc.
$618
ABBVIE INC.
$350
Medtronic USA, Inc.
$233
Boston Scientific Corporation
$224
Medtronic, Inc.
$183
BOSTON SCIENTIFIC CORPORATION
$182
PFIZER INC.
$172
Daiichi Sankyo Inc.
$167
Amgen Inc.
$166
SI-BONE, INC.
$152
Pernix Therapeutics Holdings, Inc.
$138
Novartis Pharmaceuticals Corporation
$128
Allergan, Inc.
$100
Nuvectra Corporation
$96
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$95
SI-BONE, Inc.
$81
Scilex Pharmaceuticals Inc.
$74
AstraZeneca Pharmaceuticals LP
$73
Allergan Inc.
$71
AbbVie Inc.
$68
ASSERTIO THERAPEUTICS, Inc.
$67
Alnylam Pharmaceuticals Inc.
$61
Virtus Pharmaceuticals LLC
$60
Biohaven Pharmaceutical Holding Company Ltd.
$53
Teva Pharmaceuticals USA, Inc.
$52
Avanos Medical
$50
SCILEX PHARMACEUTICALS INC.
$46
Shionogi Inc
$46
Eisai Inc.
$44
Biohaven Pharmaceuticals, Inc.
$43
Lilly USA, LLC
$38
RedHill Biopharma Inc.
$35
Assertio Therapeutics, Inc.
$35
TerSera Therapeutics LLC
$34
Valinor Pharma, LLC
$34
BioDelivery Sciences International, Inc.
$32
Purdue Pharma L.P.
$31
Forte Bio-Pharma LLC
$30
VERTEX PHARMACEUTICALS INCORPORATED
$28
Egalet US Inc
$26
Nalu Medical, Inc.
$26
Orexo US, Inc.
$25
Zimmer Biomet Holdings, Inc.
$24
Promius Pharma LLC
$22
Fidia Pharma USA Inc.
$20
Bioventus LLC
$20
Stimwave Technologies Incorporated
$19
PROTEGA PHARMACEUTIALS INC
$19
BIOTRONIK NRO, Inc.
$18
Hikma Pharmaceuticals USA
$18
Lundbeck LLC
$17
Neuronetics, Inc.
$17
INSYS Therapeutics Inc
$15
SPR Therapeutics, Inc
$14
ARBOR PHARMACEUTICALS, INC.
$13
US WorldMeds, LLC
$11
Top 3 companies account for 34.9% of total payments
Associated products mentioned in payments ›
ADAPTIVESTIM · AIMOVIG · AJOVY · Aimovig · Algovita · BIOTRONIK · BOTOX · BUNAVAIL 2.1 mg 30-count box · Cambia · DUROLANE · Dayvigo · EMGALITY · ETERNA · GENERAL PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GENERAL THERAPIES · GIVLAARI · GPS III PLATELET CONCENTRATION SYSTEM · Gralise · HYMOVIS · Horizant · INTELLIS · INTELLIS ADAPTIVESTIM · Kloxxado · LACTULOSE · LEVORPHANOL TARTRATE · LYRICA · Lucemyra/Lofexidine · MOVANTIK · Morphabond ER · Movantik · NEUROSTAR TMS THERAPY SYSTEM · NURTEC ODT · Nalocet · Nalu Neurostimulation System · OXLUMO · Octrode SCS Leads · Omnia · PRIALT · PROCLAIM · Proclaim Family of SCS IPGs · QULIPTA · RELISTOR · RELISTOR ORAL · REYVOW · ROXYBOND · SCS leads · SPECTRA WAVEWRITER · SPRINT PNS System · SPRIX · STANDARD RF DISPOSABLES · SUBSYS · SYMPROIC · Senza Spinal Cord Stimulation System · StimQ Receiver Stimulator Kit Channel A US w Receiver · Symproic · UBRELVY · VYEPTI · XTAMPZA · XTAMPZAER · Xtampza ER · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace · Zipsor · Zubsolv · iFuse Implant
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $132 per 100 Medicare services performed
Geographic Context
Interventional pain medicine physicians within 10 mi
26
Per 100K population
1.0
County median income
$74,149
Nearest hospital
NEXUS CHILDRENS HOSPITAL DALLAS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Flanagan is a clinical cardiology specialist, with above-average Medicare volume (top 20% in TX), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Flanagan experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Flanagan performed 1,701 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Flanagan receive payments from pharmaceutical companies?
Yes. Dr. Flanagan received a total of $5,982 from 58 companies across 322 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Flanagan's costs compare to other interventional pain medicine physicians in Dallas?
Dr. Flanagan's average Medicare payment per service is $105. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Flanagan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Pain Medicine Physicians in Dallas
Browse interventional pain medicine physicians in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Interventional Pain Medicine Physicians in TX
Interventional pain medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Pain Medicine Physicians in TX
Which TX interventional pain medicine physicians receive the most from drug and device companies.
By company
Nevro Corp. Payments to Doctors
See all physicians who received payments from Nevro Corp.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Collegium Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Collegium Pharmaceutical, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology